secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2026-05-20T20:37:01+00:00
Accession:  0001356576-26-000025
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus to pay $33.4M CVR milestone payment after Milestone 1 achieved March 18
--------------------------------------------------------------------------------

- Milestone 1 under July 2025 CVR Agreement achieved on March 18, 2026; triggers $0.50 per CVR payment.
- Aggregate milestone payment ~$33.4 million, payable in cash within 20 business days of May 17, 2026 Notice Date.
- Company will deposit funds with Rights Agent Equiniti Trust Company for distribution to CVR holders.
- CVRs were issued as part of prior business combination; this payment reduces future contingent liability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657626000025/0001356576-26-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657626000025/supn-20260517.htm
  HTML page:      https://secwatch.observer/filing/0001356576-26-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer